Viewing Study NCT02067767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-02-03 @ 5:39 AM
Study NCT ID: NCT02067767
Status: COMPLETED
Last Update Posted: 2016-02-22
First Post: 2014-02-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)
Sponsor: Nantes University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1 Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 infection View
None Nevirapine View
None Dolutegravir View
None Anti-retroviral agents View